FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W59586935> ?p ?o ?g. }

• W59586935 endingPage "31" @default.
• W59586935 startingPage "17" @default.
• W59586935 abstract "Mean per capita consumption of alcohol for Japanese adults has been gradually decreasing for more than15 years, while it still remains at a high level. It is pointed out that those who consume alcoholic beverages become more diversified and that the proportion of male drinkers tends to gradually decrease. On the other hand, it is estimated that the proportion of female drinkers, especially, young generation, remarkably increases. The existing cross-sectional and longitudinal studies suggest that alcohol consumption causes a variety of health- and social-related problems with accelerating increase over the past few decades except for some exceptions. The results from a patient survey show that the number of patients with alcohol dependence who receive medical treatment tends to increase. However, the percentage of patients who receive medical care is estimated to be only 5% of total number of patients with the disease, which means that there exist many untreated patients or potential patients who undergo treatment for complications only. Treatment for alcohol dependence can be divided into psychosocial and pharmacological treatment. The former is a mainstream of the treatment. Although medications available in Japanese clinical practice are limited to so called anti-alcoholic drugs, disulfiram and cyanamide, pharmacological treatment is expected to become more accessible because many potential patients can benefit from pharmacotherapy. Treatment outcomes for alcohol dependence are not necessarily high in Japan as shown by the fact that abstinence rate 1 - 3 years after treatment is 7% - 30%, while mortality rate is extremely high. However, not a few individuals are able to maintain a reduced alcohol consumption, and some are able to do so for a long period of time. It is shown that many risks of health-related problems including cancer, hypertension and intra cerebral haemorrhage and social-related problems including suicide increase with the increasing alcohol consumption in a dose-dependent manner. A certain types of disease including ischemic heart disease and cerebral infarction are indicated to have a J-shaped relationship with alcohol consumption. On the other hand, once alcohol consumption exceeds a certain level, the risks increase with the amount of alcohol consumed. Thus, reduction in alcohol consumption can lead to decrease in a large number of health-related and social-related problems in general population. Many studies indicate that reduction in alcohol consumption in patients with alcohol dependence can also lead to the improvement of these problems. In recent years, in Japan, there have been some discussions as to whether harm reduction approaches that target reduction in alcohol consumption are needed and the approaches should be aggressively introduced into clinical practice, stimulated by requests from clinicians, the established efficacy of novel therapeutic approaches on reduction in alcohol consumption and trend of various countries. The results from a survey on therapeutic goals in alcohol dependence treatment show that many experts in alcohol dependence answered that they could accept reduction in alcohol consumption (controlled drinking) as a stepwise/interim treatment goal for guiding abstinence if the patient rejects abstinence as a therapeutic goal. Regarding effective medications for reduction in alcohol consumption, most experts answered that they found the medications clinical significant and that they would use them for controlled drinking or abstinence form alcohol when available. In Japan, available drugs for alcohol dependence are extremely limited. Comments in the column for unreserved opinions on the survey questionnaire reveals that many experts hope novel agents will be developed to improve the current treatment as much as possible." @default.
• W59586935 created "2016-06-24" @default.
• W59586935 creator A5032481392 @default.
• W59586935 creator A5079882790 @default.
• W59586935 date "2013-02-01" @default.
• W59586935 modified "2023-09-23" @default.
• W59586935 title "[Reduction in alcohol consumption: therapeutic goal in alcohol dependence treatment]." @default.
• W59586935 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23659002" @default.
• W59586935 hasPublicationYear "2013" @default.
• W59586935 type Work @default.
• W59586935 sameAs 59586935 @default.
• W59586935 citedByCount "3" @default.
• W59586935 countsByYear W595869352015 @default.
• W59586935 countsByYear W595869352018 @default.
• W59586935 crossrefType "journal-article" @default.
• W59586935 hasAuthorship W59586935A5032481392 @default.
• W59586935 hasAuthorship W59586935A5079882790 @default.
• W59586935 hasConcept C118552586 @default.
• W59586935 hasConcept C127598652 @default.
• W59586935 hasConcept C150966472 @default.
• W59586935 hasConcept C185592680 @default.
• W59586935 hasConcept C2778523461 @default.
• W59586935 hasConcept C2779436514 @default.
• W59586935 hasConcept C2780687700 @default.
• W59586935 hasConcept C2781066024 @default.
• W59586935 hasConcept C2908647359 @default.
• W59586935 hasConcept C3019635848 @default.
• W59586935 hasConcept C500440147 @default.
• W59586935 hasConcept C522683910 @default.
• W59586935 hasConcept C55493867 @default.
• W59586935 hasConcept C71924100 @default.
• W59586935 hasConcept C98274493 @default.
• W59586935 hasConcept C99454951 @default.
• W59586935 hasConceptScore W59586935C118552586 @default.
• W59586935 hasConceptScore W59586935C127598652 @default.
• W59586935 hasConceptScore W59586935C150966472 @default.
• W59586935 hasConceptScore W59586935C185592680 @default.
• W59586935 hasConceptScore W59586935C2778523461 @default.
• W59586935 hasConceptScore W59586935C2779436514 @default.
• W59586935 hasConceptScore W59586935C2780687700 @default.
• W59586935 hasConceptScore W59586935C2781066024 @default.
• W59586935 hasConceptScore W59586935C2908647359 @default.
• W59586935 hasConceptScore W59586935C3019635848 @default.
• W59586935 hasConceptScore W59586935C500440147 @default.
• W59586935 hasConceptScore W59586935C522683910 @default.
• W59586935 hasConceptScore W59586935C55493867 @default.
• W59586935 hasConceptScore W59586935C71924100 @default.
• W59586935 hasConceptScore W59586935C98274493 @default.
• W59586935 hasConceptScore W59586935C99454951 @default.
• W59586935 hasIssue "1" @default.
• W59586935 hasLocation W595869351 @default.
• W59586935 hasOpenAccess W59586935 @default.
• W59586935 hasPrimaryLocation W595869351 @default.
• W59586935 hasRelatedWork W153660710 @default.
• W59586935 hasRelatedWork W1998093226 @default.
• W59586935 hasRelatedWork W2001404866 @default.
• W59586935 hasRelatedWork W2006819528 @default.
• W59586935 hasRelatedWork W2063425068 @default.
• W59586935 hasRelatedWork W2073189068 @default.
• W59586935 hasRelatedWork W2336773905 @default.
• W59586935 hasRelatedWork W2415725311 @default.
• W59586935 hasRelatedWork W3005829006 @default.
• W59586935 hasRelatedWork W2774857656 @default.
• W59586935 hasVolume "48" @default.
• W59586935 isParatext "false" @default.
• W59586935 isRetracted "false" @default.
• W59586935 magId "59586935" @default.
• W59586935 workType "article" @default.